Editor: Atta-ur-Rahman, FRS

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 6

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-340-7 (Print)
ISBN: 978-1-68108-339-1 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810833911170601


Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s disease research.

The sixth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:

  • - treatment of brain inflammation in Alzheimer’s disease with traditional medicine
  • - stem cell strategies for the modeling and therapy of Alzheimer’s disease
  • - retinal neurodegeneration in Alzheimer’s disease
  • - biological mass spectrometry for diagnosis of Alzheimer's disease

…and more.


Your Rating *